124 results
8-K
AUPH
Aurinia Pharmaceuticals Inc
14 Jun 24
Submission of Matters to a Vote of Security Holders
5:25pm
of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
Independent Proxy Advisory Service The Company recommends that shareholders review the recent report from Glass Lewis, a leading independent proxy
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 May 24
Additional proxy soliciting materials
4:11pm
PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the 2025 annual general meeting of shareholders or until
8-K
14d9519o61 5gs
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
PX14A6G
id5tdieei
1 Jun 23
Letter to shareholders
2:01pm
S-8
kea orm0bmm6k24497f
26 May 23
Registration of securities for employees
4:39pm
8-K
mr4i kacaepc
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
1knj13n
11 May 23
Letter to shareholders
11:34am
PX14A6G
45x2 oxj4k26k
5 May 23
Letter to shareholders
11:17am
PX14A6G
n5vtog3 u5
3 May 23
Letter to shareholders
2:53pm
DEFA14A
bkn9fq 3aiuwy74co6
2 May 23
Additional proxy soliciting materials
4:39pm
DEFA14A
kjzp aahat
28 Apr 23
Additional proxy soliciting materials
4:03pm